The DOJ kicked back when it secured a conviction against compounding pharmacy executive Sam Glover for a six-year drug alteration and misbranding conspiracy involving free flowing prescription forms and, well, racehorses.
Tag: pharmaceutical
Compounding the Kickback Problem – Medical Group Minute
Compounding pharmaceuticals, specific drugs for specific patients, offers tremendous benefit. The problems arise when the benefit is for the prescribing physician.
Did Ultragenyx Confuse Its Drug Crysvita With Kris Kringle? Drug Maker Settles Alleged Kickback Allegations
The allegations surrounding Ultragenyx demonstrate the AKS issues within arrangements that, to many, are difficult to envision as being referrals.
Think About Kickbacks. Then Think Again – Success in Motion Series
A physician has been indicted for his role in a compound pharmacy prescription scam that included disguised kickbacks. Lots of lessons here.
Is Someone Else Using Your Medical License? – Success in Motion
Ride along with Mark as he discusses the danger of intentionally or negligently allowing someone else to use your medical license.
Yet Another Physician Guilty of Receiving Insys/Subsys Kickbacks
In general terms, the federal Anti-Kickback Statute (“AKS”) prohibits the offer, demand, payment, and acceptance of remuneration—that is, of anything of value—for referrals.
$871.9 Million Dollar Pill Proves Hard to Swallow
But what about the rising price of settling allegations of pharmaceutical price-fixing?
“But Everyone Is Doing It!” Is Not a Great Defense to a Compliance Violation
The speed limit’s 70 mph. I’m not going to tell you how fast I’m going, but I’m going with the flow of traffic, which is traveling at a lot more than the speed limit. Would a defense of, “but everyone is speeding” actually work?
Former Drug Company CEO Pleads Guilty and Will Cooperate in Upcoming Kickback Scam Prosecution
Former CEO Michael Babich pleaded guilty last week to charges related to the plethora of kickback allegations surrounding Insys Therapeutics, Inc., and its fentanyl drug, Subsys.
U.S. Government Intervenes in 5 Kickback Based Whistleblower Cases Against Insys – Success in Motion
Ride along while Mark discusses the expanding case involving Insys Therapeutics and kickbacks paid to induce prescription of its drug, Subsys.